Samsung Medical Center
アン・テフン医学博士（MD, PhD）は、羅耘病院心臓血管センター長を務める循環器内科専門医です。冠動脈疾患（狭心症・心筋梗塞）、高血圧、心臓弁膜症、心不全、および心臓・血管系のインターベンション治療を専門としています。
高麗大学医科大学にて医学博士号を取得。高麗大学九老病院にて内科の研修を修了後、高麗大学恵化病院にて循環器内科の臨床フェローシップを修了。また、モントリオール心臓研究所にて臨床研修を受けました。
嘉泉大学吉病院医療センターにて教授および心臓血管センター長を歴任。高麗大学安岩病院および中央大学光明病院にて臨床教授として勤務。KSIC・KCCC・KVIS・KSCの会長職を歴任し、KSC会計担当およびENCORE SEOUL組織委員会委員長を務めました。
Yang Young-Joon, MD, is an orthopedic surgeon and Director of the Joint Center. He treats knee and shoulder disorders, sports injuries, foot and ankle problems, carpal tunnel syndrome, and fractures and other trauma. His practice also includes joint replacement, arthroscopic surgery, pediatric orthopedics, hip disorders, hand and foot microsurgery, hand numbness, diabetic foot, hallux valgus, and gout.
He completed his orthopedic surgery residency at Catholic Central Medical Center and an orthopedic surgery fellowship at St. Paul’s Hospital at Catholic Central Medical Center. He is a regular member of the Korean Arthroscopy, Knee, and Shoulder Societies and serves as Director of the Orthopedic Center at Naeun Hospital.
Dr. Jang Hyo Kim is an orthopedic surgeon focused on joint preservation and complex reconstruction. He specializes in arthroscopy of the shoulder, knee, ankle, elbow, and wrist. He performs joint replacement of the shoulder, knee, ankle, elbow, and hip. His spine work includes cervical and lumbar instrumentation and fusion. He also performs discectomy, laminectomy, neuroplasty, and vertebroplasty. His practice includes fracture care and muscle and ligament repair.
He is an Adjunct Professor at Kyung Hee University. He serves as Director of the Joint Center at Very Good Hospital. He previously served as chief or director at Yeonggwang General, Songjeong Sarang, Sewoori–Daejeon, Seoul Welfare, and The Barun hospitals. He was an advisory member of the Gwangju–Jeonnam Workers’ Compensation Board. He is a full member of the Korean Orthopaedic Association (KOA) and the Korean Societies of Arthroscopy, Knee, Sports Medicine, Hip, Pain, and Obesity. He holds TPI therapy certification. He completed an Ilizarov fellowship in Kurgan, Russia. He also completed training in shoulder arthroscopy.
South Korea National Health Insurance covers biologics for ankylosing spondylitis under the Rare Intractable Disease program. Patients typically pay only 10% of treatment costs. Coverage requires specific clinical criteria like active sacroiliitis on imaging and failure of conventional therapies after 3 months.
Bookimed Expert Insight: Patients should prioritize university hospitals like Severance or Asan Medical Center for initial biologic approval. These academic centers manage high patient volumes and have streamlined systems for RID registration. Major facilities also utilize digital systems like BESTcare to track treatment history and prevent documentation errors during appeals.
Patient Consensus: Patients note that documenting every medication failure is vital for insurance approval. Many find that while initial drug costs seem high, the 10% co-pay cap makes long-term biologic therapy affordable.